Preactivated thiomers: Their role in drug delivery

Expert Opinion on Drug Delivery

Volumn 12, Issue 8, 2015, Pages 1269-1281

  Ijaz, Muhammad ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Drug delivery; Polymeric excipients; Preactivated thiomers; Thiomers

Indexed keywords

CHITOSAN THIOGLYCOLIC ACID MERCAPTONICOTINAMIDE; EUDRAGIT; EXCIPIENT; LIPOSOME; MULTIDRUG RESISTANCE PROTEIN; PECTIN CYSTEINE MERCAPTONICOTINAMIDE; POLY(ACRYLIC ACID)CYSTEINE MERCAPTONICOTINAMIDE; POLYMER; THIOL DERIVATIVE; THIOL GROUP; THIOMER; UNCLASSIFIED DRUG; CHITOSAN;

CACO 2 CELL LINE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG PURIFICATION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; GELATION; LIQUID FORMULATION; MATRIX TABLET; MUCOADHESION; NONHUMAN; OXIDATION; REVIEW; ANIMAL; CHEMISTRY; HUMAN; MEDICINAL CHEMISTRY; PROCEDURES;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; POLYMERS; SULFHYDRYL COMPOUNDS;

EID: 84937216260     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2015.1005598     Document Type: Review

References (88)

1. Li S, Vert M. Biodegradable polymers: polyesters. E. Mathiowitz. Enc Control Drug Deliv, John Wiley & Sons 1999;71-93
2. Bernkop-Schnürch A, Schwarz V, Steininger S. Polymers with thiol groups: A new generation of mucoadhesive polymers? Pharm Res 1999;16(6):876-81
3. Millotti G, Perera G, Vigl C, et al. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery. Drug Deliv 2011;18(3):190-7
4. Yin L, Ding J, He C, et al. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 2009;30(29):5691-700
5. Shahnaz G, Vetter A, Barthelmes J, et al. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Int J Pharm 2012;428(1):164-70
6. Makhlof A, Werle M, Tozuka Y, et al. Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin. Int J Pharm 2010;397(1):92-5
7. Garhofer G; Medical University of Vienna. Evaluation of the corneal residence time of chitosan-Nacetylcysteine eye drops in patients with dry eye syndrome after single and multiple instillation. Clinical Trials Gov 2014. Available from: https:// clinicaltrials. gov/ct2/show/NCT01753752
8. Garhofer G; Medical University of Vienna. Local tolerability of chitosan-Nacetylcysteine eye drops in healthy young volunteers. Clinical Trials Gov 2012. Available from: https:// clinicaltrials. gov/ct2/show/NCT01278784
9. Bonengel S, Bernkop-Schnürch A. Thiomers-from bench to market. J Control Release 2014;195:120-9
10. Kast CE, Bernkop-Schnürch A. Thiolated polymers-thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 2001;22(17):2345-52
11. Iqbal J, Shahnaz G, Dünnhaupt S, et al. Preactivated thiomers as mucoadhesive polymers for drug delivery. Biomaterials 2012;33(5):1528-35
12. Brandt J, Svenson A, Carlsson J, et al. Covalent coupling of unsaturated compounds to thiol agrarose using gmma-radiation. J Solid Phase Biochem 1977;2(2):105-9
13. Carlsson J, Drevin H, Axen R. Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio) propionate, a new heterobifunctional reagent. Biochem J 1978;173:723-37
14. Norris R, Brocklehurst K. A convenient method of preparation of high-activity urease from Canavalia ensiformis by covalent chromatography and an investigation of its thiol groups with 2, 2'-dipyridyl disulphide as a thiol titrant and reactivity probe. Biochem J 1976;159:245-57
15. Bernkop-Schnürch A, Hornof M, Zoidl T. Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm 2003;260(2):229-37
16. Grassetti DR. Postoperative treatment of carcinoma patients. Google Patents 1983. Patent No. 4378364
17. Millotti G, Samberger C, Frohlich E, et al. Chitosan-graft-6-mercaptonicotinic acid: synthesis, characterization, and biocompatibility. Biomacromolecules 2009;10(11):3023-7
18. Bernkop-Schnürch A, Hoffer MH, Kafedjiiski K. Thiomers for oral delivery of hydrophilic macromolecular drugs. Expert Opin Drug Deliv 2004;1(1):87-98
19. Werle M, Bernkop-Schnürch A. Thiolated chitosans: useful excipients for oral drug delivery. J Pharm Pharmacol 2008;60(3):273-81
20. Rahmat D, Sakloetsakun D, Shahnaz G, et al. Design and synthesis of a novel cationic thiolated polymer. Int J Pharm 2011;411(1):10-17
21. Baloglu E, Ay Senygt Z, Karavana SY, et al. In vitro evaluation of mucoadhesive vaginal tablets of antifungal drugs prepared with thiolated polymer and development of a new dissolution technique for vaginal formulations. Chem Pharm Bull (Tokyo) 2011;59(8):952-8
22. Hintzen F, Hauptstein S, Perera G, et al. Synthesis and in vitro characterization of entirely S-protected thiolated pectin for drug delivery. Eur J Pharm Biopharm 2013;85(3):1266-73
23. Bernkop-Schnürch A, Kast CE, Richter MF. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J Control Release 2001;71(3):277-85
24. Krauland AH, Bernkop-Schnürch A. Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system. Eur J Pharm Biopharm 2004;57(2):181-7
25. Bernkop-Schnürch A, Clausen AE, Hnatyszyn M. Thiolated polymers: synthesis and in vitro evaluation of polymer-cysteamine conjugates. Int J Pharm 2001;226(1):185-94
26. Sarti F, Staaf A, Sakloetsakun D, et al. Thiolated hydroxyethylcellulose: synthesis and in vitro evaluation. Eur J Pharm Biopharm 2010;76(3):421-7
27. Goodwin JF, Choi S-Y. Quantification of protein solutions with trinitrobenzenesulfonic acid. Clin Chem 1970;16(1):24-31
28. Forrest HS, Fuller AT, Walker J. Chemotherapeutic agents of the sulphone type; effect of homologation on the antibacterial activity of p-methylsulphonyl-benzamidine and p-methylsulphonyl-benzylaminehydrochlorides. J Chem Soc 1948;3:1501-6
29. Dünnhaupt S, Barthelmes J, Thurner CC, et al. S-protected thiolated chitosan: synthesis and in vitro characterization. Carbohydr Polym 2012;90(2):765-72
30. Hauptstein S, Müller C, Dünnhaupt S, et al. Preactivated thiomers: evaluation of gastroretentive minitablets. Int J Pharm 2013;456(2):473-9
31. Hauptstein S, Bonengel S, Rohrer J, et al. Preactivated thiolated poly (methacrylic acid-co-ethyl acrylate): synthesis and evaluation of mucoadhesive potential. Eur J Pharm Sci 2014;63:132-9
32. Bonengel S, Haupstein S, Perera G, et al. Thiolated and S-protected hydrophobically modified cross-linked poly (acrylic acid)-A new generation of multifunctional polymers. Eur J Pharm Biopharm 2014;88(2):390-6
33. Laffleur F, Roggla J, Idrees MA, et al. Chemical Modification of Hyaluronic Acid for Intraoral Application. J Pharm Sci 2014;103(8):2414-23
34. Solhi L, Schonbichler SA, Dünnhaupt S, et al. Synthesis and in vitro characterization of a preactivated thiomer via polymerization reaction. Biomacromolecules 2012;13(10):3054-63
35. Winterbourn CC, Metodiewa D. Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic Biol Med 1999;27(3):322-8
36. Xie D, Chung I-D, Wu W, et al. An amino acid-modified and non-HEMA containing glass-ionomer cement. Biomaterials 2004;25(10):1825-30
37. Varaprasad D, Rosthauser J, Winston A. Hydroxamic acid polymers. Effect of structure on the chelation of iron in water: II. J Polym Sci 1984;22(9):2131-43
38. Romack T, Maury E, DeSimone J. Precipitation polymerization of acrylic acid in supercritical carbon dioxide. Macromolecules 1995;28(4):912-15
39. Barthelmes J, Rahmat D, et al. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties. Mol Pharm 2012;9(5):1331-41
40. Müller C, Verroken A, Iqbal J, et al. Thiolated chitosans: in vitro comparison of mucoadhesive properties. J Appl Polym Sci 2012;124(6):5046-55
41. Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev 2005;57(11):1556-68
42. Albrecht K, Bernkop-Schnürch A. Thiomers: forms, functions and applications to nanomedicine. Nanomdeicine 2007;2(1):41-50
43. Bernkop-Schnürch A, Hornof M, Guggi D. Thiolated chitosans. Eur J Pharm Biopharm 2004;57(1):9-17
44. Barthelmes J, Perera G, Hombach J, et al. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder. Int J Pharm 2011;416(1):339-45
45. Laffleur F, Shahnaz G, Islambulchilar Z, et al. Design and in vitro evaluation of a novel polymeric excipient for buccal applications. Future Med Chem 2013;5(5):511-22
46. Müller C, Ma BN, Gust R, Bernkop-Schnürch A. Thiopyrazole preactivated chitosan: combining mucoadhesion and drug delivery. Acta Biomater 2013;9(5):6585-93
47. Gurny R, Ibrahim H, Buri P. The development and use of in situ formed gels, triggered by pH. Biopharm Ocul Drug Deliv (Edman, P., ed.), CRC Press, Boca Raton, FL, USA 1993;81-90
48. Edsman K, Carlfors J, Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci 1998;6(2):105-12
49. Bromberg L. Enhanced nasal retention of hydrophobically modified polyelectrolytes. J Pharm Pharmacol 2001;53(1):109-14
50. Deasy P, Quigley KJ. Rheological evaluation of deacetylated gellan gum (Gelrite) for pharmaceutical use. Int J Pharm 1991;73(2):117-23
51. Paulsson M, Hägerstrom H, Edsman K. Rheological studies of the gelation of deacetylated gellan gum (Gelrite-) in physiological conditions. Eur J Pharm Sci 1999;9(1):99-105
52. Hauptstein S, Hintzen F, Müller C, et al. Development and in vitro evaluation of a buccal drug delivery system based on preactivated thiolated pectin. Drug Dev Ind Pharm 2014;40(11):1530-7
53. Palmberger TF, Albrecht K, Loretz B, et al. Thiolated polymers: evaluation of the influence of the amount of covalently attached L-cysteine to poly (acrylic acid). Eur J Pharm Biopharm 2007;66(3):405-12
54. Friedl HE, Dünnhaupt S, Waldner C, et al. Preactivated thiomers for vaginal drug delivery vehicles. Biomaterials 2013;34(32):7811-18
55. Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2012;64:4-17
56. Huang W, Lee SL, Lawrence XY. Mechanistic approaches to predicting oral drug absorption. AAPS J 2009;11(2):217-24
57. Blanquet S, Zeijdner E, Beyssac E, et al. A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm Res 2004;21(4):585-91
58. Bernkop-Schnürch A, Kast C, Guggi D. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J Control Release 2003;93(2):95-103
59. Muranishi S. Absorption enhancers. Crit Rev Ther Drug Carrier Syst 1989;7(1):1-33
60. Cereijido M, Meza I, Martinez-Palomo A. Occluding junctions in cultured epithelial monolayers. Am J Physiol 1981;240:C96-C102
61. Madara JL, Dharmsathaphorn K. Occluding junction structure-function relationships in a cultured epithelial monolayer. J Cell Biol 1985;101(6):2124-33
62. Simon DB, Lu Y, Choate KA, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+resorption. Science 1999;285(5424):103-6
63. Wang X, Iqbal J, Rahmat D, et al. Preactivated thiomers: permeation enhancing properties. Int J Pharm 2012;438(1):217-24
64. Schipper NG, Vårum KM, Stenberg P, et al. Chitosans as absorption enhancers of poorly absorbable drugs: 3: influence of mucus on absorption enhancement. Eur J Pharm Sci 1999;8(4):335-43
65. Meaney C, O'Driscoll C. Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models. Eur J Pharm Sci 1999;8(3):167-75
66. Dünnhaupt S, Barthelmes J, Iqbal J, et al. In vivo evaluation of an oral drug delivery system for peptides based on Sprotected thiolated chitosan. J Control Release 2012;160(3):477-85
67. Werle M. Natural and synthetic polymers as inhibitors of drug efflux pumps. Pharm Res 2008;25(3):500-11
68. Silverman JA. Multidrug-resistance transporters. In: Membrane transporters as drug targets. Springer, US; 2002. p. 353-86
69. Hugger ED, Audus KL, Borchardt RT. Effects of poly (ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers. J Pharm Sci 2002;91(9):1980-90
70. Kabanov AV, Batrakova EV, Miller DW. Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Adv Drug Deliv Rev 2003;55(1):151-64
71. Jha S, Karnani N, Lynn AM, et al. Covalent modification of cysteine 193 impairs ATPase function of nucleotide-binding domain of a Candida drug efflux pump. Biochem Biophys Res Commun 2003;310(3):869-75
72. Werle M, Hoffer M. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release 2006;111(1):41-6
73. Varma MV, Ashokraj Y, Dey CS, et al. P-glycoprotein inhibitors and their screening: A perspective from bioavailability enhancement. Pharm Res 2003;48(4):347-59
74. Profit L, Eagling VA, Back DJ. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors. Aids 1999;13(13):1623-7
75. Saha P, Yang JJ, Lee V. Existence of a pglycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells. Invest Ophthalmol Vis Sci 1998;39(7):1221-6
76. Hombach J, Palmberger TF, Bernkop-Schnürch A. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin. J Pharm Sci 2009;98(2):555-64
77. Kast CE, Valenta C, Leopold M, et al. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J Control Release 2002;81(3):347-54
78. Mortazavi SA, Smart JD. Factors influencing gel-strengthening at the mucoadhesive-mucus interface. J Pharm Pharmacol 1994;46(2):86-90
79. Garg S, Sharma S. Gastroretentive drug delivery systems, Business Brief: Pharmatech World Markets Research Centre 2003;160-6
80. Guggi D, Marschütz MK, Bernkop-Schnürch A. Matrix tablets based on thiolated poly (acrylic acid): pH-dependent variation in disintegration and mucoadhesion. Int J Pharm 2004;274(1):97-105
81. Allen TM. Liposomal drug formulations. Drugs 1998;56(5):747-56
82. Gradauer K, Vonach C, Leitinger G, et al. Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties. Int J Nanomedicine 2012;7:2523-34
83. Mertins O, Dimova R. Binding of chitosan to phospholipid vesicles studied with isothermal titration calorimetry. Langmuir 2011;27(9):5506-15
84. Mertins O, Schneider PH, Pohlmann AR, et al. Interaction between phospholipids bilayer and chitosan in liposomes investigated by 31P NMR spectroscopy. Colloids Surf B 2010;75(1):294-9
85. Zhuang J, Ping Q, Song Y, et al. Effects of chitosan coating on physical properties and pharmacokinetic behavior of mitoxantrone liposomes. Int J Nanomedicine 2010;5:407-16
86. Gradauer K, Dünnhaupt S, Vonach C, et al. Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties. J Control Release 2013;165(3):207-15
87. Lai SK, Wang Y-Y, Wirtz D, et al. Micro-and macrorheology of mucus. Adv Drug Deliv Rev 2009;61(2):86-100
88. Gradauer K, Barthelmes J, Vonach C, et al. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats. J Control Release 2013;172(3):872-8